LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)
Rxsight, Inc. · Decision date Sep 2, 2025
What did the FDA approve?
FDA records P160055/S045 as a supplement to PMA P160055, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Sep 2, 2025.
FDA approval order statement
approval for the professional and patient labeling to include the outcomes of the Post-approval study (PAS) LAL/LDD Postmarket RCT
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Ophthalmic
- Decision date
- Sep 2, 2025
- FDA change category
- Labeling Change - PAS
Regulatory record facts
- Identifier
- P160055/S045
- Regulatory pathway
- PMA supplement
- Applicant
- Rxsight, Inc.
- Product code
- PZK
- Decision code
- APPR
- Decision date
- Sep 2, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light adjustable lens (LAL) and light delivery device (LDD).
- Applicant
- Rxsight, Inc.
- Product code
- PZK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160055. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160055 · Original PMA
LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)
P160055/S045 received
Application receipt date recorded by FDA.
P160055/S045 · FDA decision
Normal 180 Day Track No User Fee
P160055/S052 · Related supplement
Light Adjustable Lens and Light Delivery Device
P160055/S055 · Related supplement
RxSight Light Adjustable Lens; Light Delivery Device
P160055/S054 · Related supplement
RxSight Light Adjustable Lens; Light Delivery Device
P160055/S056 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
P160055/S058 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
P160055/S057 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
Timeline entries are records held by MedtechLedger for P160055. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160055
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Rxsight, Inc. | PMA approval | Nov 22, 2017 | FDA | |
Light Adjustable Lens and Light Delivery DeviceP160055/S052 | Rxsight, Inc. | PMA supplement | Oct 8, 2025 | FDA |
| Rxsight, Inc. | PMA supplement | Jun 8, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Jun 26, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Nov 5, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Rxsight, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 100 Columbia, Aliso Viejo, CA, 92656
Sources and methodology
- Original FDA record: P160055/S045
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





